Investing.com - Fresenius Medical Care (NYSE:FMS) ADR reported on Tuesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Fresenius Medical Care ADR announced earnings per share of $0.5101 on revenue of $5.27B. Analysts polled by Investing.com anticipated EPS of $0.4964 on revenue of $5.2B.
Fresenius Medical Care ADR shares are down 14.9% from the beginning of the year, still down 21.34% from its 52 week high of $42.45 set on June 16, 2021. They are under-performing the EUR/USD which is down 0% from the start of the year.
Fresenius Medical Care ADR follows other major Healthcare sector earnings this month
Fresenius Medical Care ADR's report follows an earnings beat by J&J on January 25, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.
Roche Holding ADR had matched expectations on February 3 with fourth quarter EPS of $1.29 on revenue of $17.54B, compared to forecast for EPS of $1.29 on revenue of $17.1B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar